Cellbox Solutions GmbH is expanding its product portfolio: The Cellbox Solutions Packaging, which enables the best-in-class transport of living cell and tissue cultures, is now joined by the CBS Naturally-3D Kit. The innovative new product contains the CBS Transport Gel and the CBS Easy Release solution.
The CBS Transport Gel is a UPM’s nanofibrillar cellulose based hydrogel that provides an artificial extracellular matrix for the cultivation of 3D cell cultures in an optimal environment. To complement the transport gel, Cellbox Solutions also offers the CBS Easy Release mixture to dissolve the hydrogel in a cell-friendly manner. Together this highly effective product combination facilitates the transport of the most complex and sensitive cell cultures with the possibility to easily recover the material post-transport.
Animal-free and reusable transport
Cellbox Solutions is not only establishing a unique transport technology for living cells. In collaboration with UPM Biomedicals, its CBS Naturally-3D Kit also provides a plant derived and animal-free shipping solution.
“The market for 3D cell cultures continues to grow strongly – as a result we are seeing that more and more of our customers are looking for special transport options,” says Dr. Corné Swart, Executive Director Business Development & Global Sales at Cellbox Solutions. “Cellbox Solutions clearly recognized the need and has taken a forward-looking approach. With the CBS Naturally-3D Kit and the help of UPM Biomedicals, we are very pleased to now be able to offer our customers an environmentally friendly product designed for this exact purpose.”
“Cellbox Solutions and UPM Biomedicals are establishing new standards in live cell transport and shipping through the CBS Naturally-3D kit,” said Tony Kiuru, Business Development Manager at UPM Biomedicals. “We are proud of the outcome and pleased to support Cellbox Solutions in their vision.”
About Cellbox Solutions
Founded in 2017, Cellbox Solutions GmbH focuses on innovative logistics solutions for the global BioMedTech industry. We have the vision to change the future of healthcare. For this, we offer a solution with Cellbox so that healthcare providers can fully focus on treating patients with the latest therapies. Our goal is to provide living cell logistics solutions that enable life-sustaining therapy designs that are accessible to all. Our portable CO2 incubator, the Cellbox, provides a controlled environment for the transport of living cells and biological structures. Temperature and CO2 levels can be adjusted to ensure optimal incubation conditions.
We deliver renewable and responsible solutions and innovate for a future beyond fossils across six business areas: UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers and UPM Plywood. As the industry leader in responsibility we are committed to the UN Business Ambition for 1.5°C and the science-based targets to mitigate climate change. We employ 18,000 people worldwide and our annual sales are approximately EUR 8.6 billion. Our shares are listed on Nasdaq Helsinki Ltd. UPM Biofore – Beyond fossils.
About UPM Biomedicals
UPM Biomedicals is the forerunner in producing high quality nanofibrillar cellulose for medical and life science applications. More than 300 patents protect the existing and future products that rely on the Finnish birch pulp. We actively collaborate with universities, research centers and key industrial partners on future innovations and products in the field of high throughput drug screening, personalised medicine, advanced cell therapies, 3D bioprinting, tissue engineering and advanced wound care.